Related Experiment Video

Updated: Aug 4, 2026

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

Apoptosis and prognostic factors in myelodysplastic syndromes

K Shimazaki1, K Ohshima, J Suzumiya

  • 1Department of Pathology, School of Medicine, Fukuoka University, Japan.

Leukemia & Lymphoma
|May 10, 2002
PubMed

Insights

Myelodysplastic syndromes (MDS) involve ineffective blood cell production due to high cell death rates in the bone marrow. This review explores how apoptosis and proliferation impact MDS patient prognosis and outcomes.

Area of Science:

  • Hematology
  • Cell Biology
  • Oncology

Background:

  • Myelodysplastic syndromes (MDS) are characterized by low blood counts despite a cellular bone marrow.
  • Ineffective hematopoiesis, driven by increased apoptosis of hematopoietic cells, is a key feature of MDS.
  • MDS is prognostically heterogeneous, with some patients experiencing prolonged survival and others facing rapid progression or transformation to leukemia.

Purpose of the Study:

  • To review the relationship between prognosis and the processes of apoptosis and proliferation in hematopoietic cells within the bone marrow of MDS patients.
  • To elucidate how cellular dynamics contribute to the diverse clinical outcomes observed in myelodysplastic syndromes.

Main Methods:

  • Literature review focusing on studies investigating apoptosis and proliferation in MDS bone marrow.
  • Analysis of research correlating these cellular processes with patient prognosis and survival.
  • Synthesis of findings on the heterogeneity of MDS based on hematopoietic cell dynamics.

Main Results:

  • Consistent evidence indicates a high apoptotic rate in the bone marrow of MDS patients.
  • Elevated proliferation rates are also observed in the bone marrow of individuals with MDS.
  • The interplay between apoptosis and proliferation in hematopoietic cells is linked to the variable prognosis seen in MDS.

Conclusions:

  • Apoptotic and proliferative processes in hematopoietic cells are central to the pathophysiology of MDS.
  • Understanding these cellular mechanisms is crucial for predicting prognosis and guiding therapeutic strategies in myelodysplastic syndromes.
  • Further research into the molecular regulation of apoptosis and proliferation may reveal novel therapeutic targets for MDS.

More Related Videos

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...